Salvaging ischemic myocardium after myocardial infarction.
Today's sophisticated diagnostic techniques make it possible to determine, virtually at the bedside, the site and size of an infarct and its effect on the patient's hemodynamic status. Thus, it is now possible to identify the patient who will benefit from aggressive therapy and to spare those who do not need or will not be helped by such treatment. Three phases of management are discussed.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000790:Angiocardiography; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002315:Cardiopulmonary Bypass; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D004285:Dogs; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy; D010347:Patient Care Planning; D012306:Risk
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal